BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34667026)

  • 1. Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.
    Stopsack KH; Nandakumar S; Arora K; Nguyen B; Vasselman SE; Nweji B; McBride SM; Morris MJ; Rathkopf DE; Slovin SF; Danila DC; Autio KA; Scher HI; Mucci LA; Solit DB; Gönen M; Chen Y; Berger MF; Schultz N; Abida W; Kantoff PW
    Clin Cancer Res; 2022 Jan; 28(2):318-326. PubMed ID: 34667026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
    Koga Y; Song H; Chalmers ZR; Newberg J; Kim E; Carrot-Zhang J; Piou D; Polak P; Abdulkadir SA; Ziv E; Meyerson M; Frampton GM; Campbell JD; Huang FW
    Clin Cancer Res; 2020 Sep; 26(17):4651-4660. PubMed ID: 32651179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
    Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
    Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
    PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer genetic alterations in Hispanic men.
    Arenas-Gallo C; Rhodes S; Garcia JA; Weinstein I; Prunty M; Lewicki P; Brant A; Basourakos SP; Barbieri CE; Lifschutz N; Schumacher FR; Shoag JE
    Prostate; 2023 Sep; 83(13):1263-1269. PubMed ID: 37301735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
    Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
    Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
    Jayachandran J; Bañez LL; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ;
    Cancer; 2009 Nov; 115(22):5263-71. PubMed ID: 19670453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
    Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
    Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
    Bennett CL; Ferreira MR; Davis TC; Kaplan J; Weinberger M; Kuzel T; Seday MA; Sartor O
    J Clin Oncol; 1998 Sep; 16(9):3101-4. PubMed ID: 9738581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.
    Lynch SM; Sorice K; Tagai EK; Handorf EA
    Cancer; 2020 Jan; 126(9):1949-1957. PubMed ID: 32012234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.
    Fowler JE; Bigler SA; Bowman G; Kilambi NK
    J Urol; 2000 Jan; 163(1):137-42. PubMed ID: 10604331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
    Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
    Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in operating characteristics of prostate cancer screening tests.
    Smith DS; Bullock AD; Catalona WJ
    J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.
    Sucheston LE; Bensen JT; Xu Z; Singh PK; Preus L; Mohler JL; Su LJ; Fontham ET; Ruiz B; Smith GJ; Taylor JA
    PLoS One; 2012; 7(3):e30950. PubMed ID: 22479307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.
    Nettey OS; Walker AJ; Keeter MK; Singal A; Nugooru A; Martin IK; Ruden M; Gogana P; Dixon MA; Osuma T; Hollowell CMP; Sharifi R; Sekosan M; Yang X; Catalona WJ; Kajdacsy-Balla A; Macias V; Kittles RA; Murphy AB
    Urol Oncol; 2018 Nov; 36(11):501.e1-501.e8. PubMed ID: 30236853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
    Defever K; Platz EA; Lopez DS; Mondul AM
    Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
    Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
    J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.